On-Demand CME Videos
Not Just Skin Deep: Revealing New Strategies to Manage Vitiligo: Online CME Activity
About
CME Seminar-in-Depth- October 22, 2022 3:15 PM PDT.
Not Just Skin Deep: Revealing New Strategies to Manage Vitiligo
This activity is supported by an educational grant from Incyte.
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
November 15, 2022
November 15, 2024
Learning Objectives
At the completion of this activity, participants should be better able to:
Overview of the pathophysiology of vitiligo
Report on the key data for JAK inhibitors for the management of vitiligo
Explain tactics to prevent and manage AE with JAK inhibitors
Recognize strategies to optimize care for patients with vitiligo
Intended Audience
Faculty
Seemal Desai, MD
Clinical Assistant Professor
Department of Dermatology
University of Texas Southwestern Medical Center
Dallas, TX
Pearl Grimes, MD
Director and Clinical Professor
Vitiligo and Pigmentation Institute of Southern California
Los Angeles, CA
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada and CMEsquared. The University of Nevada is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
CONFLICTS OF INTEREST/DISCLOSURES
In accordance with the ACCME Standards for Commercial Support, balance, independence, objectivity, and scientific rigor are ensured in all CME activities. This requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any ineligible companies. In addition, the content of this material has been approved by an independent peer reviewer.
Disclosures are as follows:
Grant/Research Support: AbbVie, Incyte, Dermavant, AOBiome,
Consultant: Galderma, Almirall, Ferndale, BMS, AbbVie, Verrica, UCB, Ortho, Scientis, EPI, Avita, Eli Lilly, Leo, Pfizer, Incyte, L’Oreal, Beiersdorf, J&J
Speakers’ Bureau or Honoraria: Dermavant, Galderma, Pfizer
has disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.
The planners have disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.
The University of Nevada discloses that all relevant conflicts have been satisfactorily mitigated.